Literature DB >> 11126832

The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study.

D N Mohr1, M D Silverstein, J A Heit, T M Petterson, W M O'Fallon, L J Melton.   

Abstract

OBJECTIVES: To estimate the incidence and determine predictors of venous stasis syndrome and venous ulcers after deep venous thrombosis and pulmonary embolism. PATIENTS AND METHODS: This population-based retrospective cohort study reviewed medical records of 1527 patients with incident deep venous thrombosis or pulmonary embolism between 1966 and 1990. We recorded baseline characteristics, event type (deep venous thrombosis with or without pulmonary embolism or pulmonary embolism alone), leg side and site of deep venous thrombosis (proximal with or without distal deep venous thrombosis vs distal deep venous thrombosis alone), and venous stasis syndrome and venous ulcer.
RESULTS: Two hundred forty-five patients developed venous stasis syndrome. One-year, 5-year, 10-year, and 20-year cumulative incidence rates were 7.3%, 14.3%, 19.7%, and 26.8%, respectively. By 20 years the cumulative incidence of venous ulcers was 3.7%. Patients with deep venous thrombosis with or without pulmonary embolism were 2.4-fold (95% confidence interval, 1.7-fold-3.2-fold) more likely to develop venous stasis syndrome than patients with pulmonary embolism and no diagnosed deep venous thrombosis. In patients aged 40 years or younger with proximal compared with distal-only deep venous thrombosis, venous stasis syndrome was 3.0-fold more likely (95% confidence interval, 1.6-fold-4.7-fold). In patients with unilateral leg deep venous thrombosis, venous stasis syndrome usually developed in the concordant leg (P < .001). There was a 30% (95% confidence interval, 2%-62%) increased risk for venous ulcer per decade of age at the incident venous thromboembolism.
CONCLUSIONS: The cumulative incidence of venous stasis syndrome continues to increase for 20 years after venous thromboembolism. Pulmonary embolism alone is less likely to cause venous stasis syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 11126832     DOI: 10.4065/75.12.1249

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  24 in total

1.  Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study.

Authors:  Aneel A Ashrani; Marc D Silverstein; Thom W Rooke; Brian D Lahr; Tanya M Petterson; Kent R Bailey; L Joseph Melton; John A Heit
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

Review 3.  The epidemiology of venous thromboembolism in the community.

Authors:  John A Heit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

Review 4.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.

Authors:  Scott D Grosse; Richard E Nelson; Kwame A Nyarko; Lisa C Richardson; Gary E Raskob
Journal:  Thromb Res       Date:  2015-11-24       Impact factor: 3.944

Review 5.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

6.  Venous thromboembolism and subsequent permanent work-related disability.

Authors:  S K Braekkan; S D Grosse; E M Okoroh; J Tsai; S C Cannegieter; I A Naess; S Krokstad; J-B Hansen; F E Skjeldestad
Journal:  J Thromb Haemost       Date:  2016-08-17       Impact factor: 5.824

7.  Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity.

Authors:  A B Pedersen; V Ehrenstein; S K Szépligeti; H T Sørensen
Journal:  Osteoporos Int       Date:  2017-09-05       Impact factor: 4.507

Review 8.  Incidence and cost burden of post-thrombotic syndrome.

Authors:  Aneel A Ashrani; John A Heit
Journal:  J Thromb Thrombolysis       Date:  2009-02-18       Impact factor: 2.300

Review 9.  The epidemiology of venous thromboembolism in the community: implications for prevention and management.

Authors:  John A Heit
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

10.  Development of national performance measures on the prevention and treatment of venous thromboembolism.

Authors:  Dale W Bratzler
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.